Compound library / Diabetes
Long-acting basal insulin analog providing roughly 24-hour background insulin coverage for type 1 or type 2 diabetes.
| Category | Diabetes |
|---|---|
| Typical route | Subcutaneous |
| Half-life | ~12-24 hours (flat, long-acting profile) |
| Common dose range | Individualized starting dose (often ~10 units/day or weight-based), titrated by a physician based on blood glucose |
| Typical cycle length | Ongoing, long-term |
BioHack Track models Insulin Glargine (Lantus/Basaglar) at a half-life of 18 hours, so every dose you log is decayed against that curve and the app shows what is still circulating — not just what you typed.
Pre-filled pen or vial; no reconstitution needed, but never dilute or mix with other insulins unless specifically directed.
Refrigerate unopened pens/vials; in-use pens are typically good at room temperature for ~28 days — check label.
Prescription medication. Risk of hypoglycemia, especially if doses, meals, or activity change; injection site rotation matters for consistent absorption.
Track Insulin Glargine (Lantus/Basaglar) in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.
These open a search of each database for Insulin Glargine (Lantus/Basaglar) — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.
General reference compiled for use inside the app, not medical advice and not a recommendation to take anything. Dose ranges are what is commonly discussed, not a prescription. Talk to a qualified healthcare professional.